目的:探讨改良23G玻璃体切割系统在玻璃体视网膜疾病中的应用,评估其实用性及安全性。方法:回顾性分析2009-08/2010-02行改良23G玻璃体切除术治疗的患者112例112眼。其中孔源性视网膜脱离53例,牵拉性视网膜脱离59例。观察手术效果和并发症。术后随访1～12mo。结果:所有病例均顺利完成手术,术中术后均无严重并发症发生,术后视力得到不同程度改善。结论:改良23G玻璃体切除术广泛适用于玻璃体视网膜疾病,手术效果好,术后恢复快,并发症较少,是一种安全有效的微创手术方法。

AIM:To investigate the clinical application of improved 23-gauge vitrectomy system in the treatment of vitreoretinopathy disease and evaluate its efficacy and safety.·METHODS:A retrospective study of 112 cases(112 eyes) who received improved 23-gauge vitrectomy from August 2009 to February 2010 was retrospectively studied. The diseases included rhegmatogenous retinal detachment(53 cases),tractional retinal detachment(59 cases).The main observation were the surgical effects and complications.The follow-up time was from 1 month to 12 months.·RESULTS:All cases were successfully completed without significant complications.The best-corrected visual acuity was improved in different degree.·CONCLUSION:Improved 23-gauge vitrectomy system with better curative effect,faster postoperative recovery and few complications is an effective and safe surgical technique for all vitreoretinopathy diseases.

R779.6